DAC-CEL T4— 510(k) K791231

Substantially Equivalent

Burroughs Wellcome Co.

FDA 510(k) clearance K791231 for DAC-CEL T4, Substantially Equivalent on 1979-09-04. Applicant: Burroughs Wellcome Co..

Clearance details

Applicant: Burroughs Wellcome Co.
Product code: Code CDX
Advisory panel: Clinical Chemistry
Date received: 1979-07-02
Decision date: 1979-09-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.